R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA
Associate Professor and Director, Phase I Clinical Trials Section
Winship Cancer Institute of Emory University
Dr. Harvey is Director, Phase I Clinical Trials Section, Winship Cancer Institute and an Associate Professor in Hematology/Medical Oncology and Pharmacology at the Emory University School of Medicine. Dr. Harvey received his Pharmacy degrees from the University of North Carolina (UNC). He completed reisdency training at the University of Kentucky and Hematology/Oncology specialty training at UNC. Dr. Harvey is a former President of the Hematology/Oncology Pharmacy Association and has over 75 peer-reviewed publications in hematology/oncology and clinical pharmacology. He is active in the American Society of Clinical Oncology (Cancer Research Committee), the American Society for Clinical Pharmacology and Therapeutics, and the American Society of Hematology. His research focuses on applying clinical pharmacology principles for improved cancer treatment outcomes.
Saturday, November 3
8:00 AM – 9:00 AM